| Report ID |
22634 |
| Drug Identification Number |
02285614 |
| Brand name |
ALVESCO |
| Common or Proper name |
ciclesonide |
| Company Name |
ASTRAZENECA CANADA INC |
| Active Ingredient(s) |
CICLESONIDE |
| Strength(s) |
200MCG |
| Dosage form(s) |
AEROSOL, METERED DOSE |
| Route of administration |
INHALATION |
| Packaging size |
120 doses |
| ATC code |
R03BA |
| ATC description |
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
2017-10-06 |
| Actual start date |
|
| Estimated end date |
2017-10-20 |
| Actual end date |
2017-10-02 |
| Shortage status |
Avoided shortage |
| Updated date |
2017-10-02 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
